PHARMACEUTICAL GMP • QUALITY • VALIDATION

GMP compliance that holds up in real execution.

AVISAN helps pharmaceutical manufacturers and distribution companies turn requirements into controlled, evidence-based, inspection-defensible execution.

WHO GMPEU GMPPIC/SICH Q9 & Q10

AVISAN CONTROL MODEL

Design
Execution
Verification
PROVEN BYEvidence

FOCUSED TECHNICAL REVIEW PACKAGES

Focused Reviews. Clear Priorities. Practical Next Steps.

AVISAN offers structured, risk-based technical review packages to help pharmaceutical manufacturers identify critical compliance gaps, assess supporting evidence, and define practical improvement priorities before committing to broader remediation or implementation projects.

Subject to agreed scope and system complexity.

Industries & operations

Experience shaped around operational risk

AVISAN support is structured around the product, process and facility risks that define each operating environment.

01

Sterile & Parenteral

Aseptic processing, terminal sterilization, media fill, contamination control and sterile utilities.

02

Oral Solid Dosage

Tablets, capsules, coating, granulation, cleaning and general or potent manufacturing.

03

Softgel & Potent

Containment, cross-contamination control, cleaning validation and engineering controls.

04

Biotech Manufacturing

Upstream and downstream operations, classified flows, utilities and process support systems.

05

Distribution & Warehousing

GDP, storage, cold chain, temperature mapping, transport and vendor governance.

How we work

Control must be demonstrated — not assumed.

We connect documents, decisions and shopfloor evidence so the system can defend itself under inspection.

Documents describe the system. Evidence proves it is in control.
  1. 01Define scope & critical risks
  2. 02Review evidence & system design
  3. 03Test execution reality
  4. 04Build a risk-based roadmap
  5. 05Support closure & readiness

Selected experience

Selected project experience

Representative scopes from real pharmaceutical work. Client and site identities remain confidential.

01

CLIENT CONFIDENTIAL

Jul 2024–PresentSterile injectable company

GMP Training & Quality System Implementation

Customized GMP training for production, QC and QA, together with integrated QMS implementation across SOPs, deviation, CAPA and internal audit, plus ongoing compliance and inspection-readiness support.

02

CLIENT CONFIDENTIAL

Dec 2022–Apr 2024Sterile manufacturing site

End-to-End GMP Compliance & Validation Program

Comprehensive support covering PW/WFI qualification, HVAC, process and cleaning validation, GMP documentation, personnel training and operational readiness through GMP approval.

03

CLIENT CONFIDENTIAL

Mar–May 2023Sterile manufacturing facility

Purified Water & WFI System Qualification

Design review, FAT/SAT supervision, PQ protocol preparation and execution, sampling and monitoring strategy, and risk-based validation documentation.

04

CLIENT CONFIDENTIAL

Current engagementParenteral project

End-to-End GMP Execution Support

Quality-system architecture, core GMP documentation, layout and flow review, qualification alignment, practical execution support and personnel readiness.

05

CLIENT CONFIDENTIAL

Selected projectPharmaceutical storage

Temperature Mapping & Control Evidence

Mapping strategy, protocol and sensor-location review, execution support, data assessment, deviation handling and final-report structure.

06

CLIENT CONFIDENTIAL

Selected projectPharmaceutical facility

Documentation, Layouts & Workforce Readiness

GMP documentation development, layout and personnel/material-flow review, role-based training and implementation support.

Insights

AVISAN GMP Review Notes

Short, experience-led observations on the gaps between paper compliance and controlled execution.

FLOW & EXECUTION

An approved flow map does not prove shopfloor control

Design is defensible only when actual personnel and material movement are verified against it.

READ NOTE ↗
IMPACT ASSESSMENT

Reanalysis planned does not defend the impact period

The risk window must start from the earliest plausible failure — not the next scheduled test.

READ NOTE ↗
QUALIFICATION

Qualified does not always mean process-ready

A passed protocol is not enough when operating ranges, alarms and routine decisions remain unverified.

READ NOTE ↗

About AVISAN

A specialist GMP consulting and execution group

AVISAN brings together pharmaceutical quality, validation, engineering and regulatory thinking to help organizations build systems that work in routine operation — not only on paper. Engagements can be delivered remotely, on-site or through a hybrid model across the Middle East.

Practical

Recommendations are designed for implementation.

Risk-based

Effort follows product, patient and compliance risk.

Evidence-driven

Control is demonstrated through traceable evidence.

Inspection-defensible

Decisions and execution must withstand challenge.